NasdaqGM:SYMMachinery
Symbotic (SYM) Valuation Check After Equity Raise, Q4 Margin Gains and Medline-Backed Backlog Growth
Symbotic (SYM) just wrapped up a $425 million equity raise and paired it with upbeat Q4 numbers, including better margins and a hefty $22.5 billion backlog anchored by new customer Medline.
See our latest analysis for Symbotic.
Despite some choppiness over the past week, Symbotic’s 1 month share price return of roughly 10 percent sits within a much stronger backdrop. Year to date share price gains are near 139 percent and the three year total shareholder return is above 435 percent,...